IFNA1 and myeloid sarcoma: In previous two-dimensional electrophoresis studies, some differentially expressed proteins (DEPs) have been highlighted in PBMCs from IFN-treated MS patients in comparison to untreated ones as well as healthy controls (HCs) [6,7].